Trial intelligence / Profile preview

Effect of oral cotrimoxazole and intranasal mupirocin on Staphylococcus aureus colonization in hemodialysis patients

IRCT2016122331527N1Phase 3Completed

Sponsor
Shahroud University of Medical Sciences
Start
Feb 2017
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of trimethoprim + sulfamethoxazole and mupirocin in staphylococcal carrier state, sponsored by Shahroud University of Medical Sciences. Started Feb 2017; status: completed.

02

Drugs

trimethoprim + sulfamethoxazolemupirocin
03

Conditions

staphylococcal carrier state

Beyond the preview

Go deeper on IRCT2016122331527N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016122331527N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call